Related Experiment Videos
Band 3 peptides inhibit deoxy S polymerization: viscosity studies
E H Danish1, D W Lundgren, J W Harris
1Department of Pediatrics, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH 44109-1998.
American Journal of Hematology
|January 1, 1993
Summary
N-terminal band 3 peptides inhibit sickle cell disease (SCD) by preventing deoxyhemoglobin S polymerization. Mirror-image peptides show significant therapeutic potential by forming binary complexes, reducing polymer formation and gelation.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Sickle cell disease (SCD) is characterized by the polymerization of deoxyhemoglobin S (deoxy S).
- N-terminal band 3 peptides have shown potential in inhibiting this polymerization process.
Purpose of the Study:
- To investigate the mechanism of inhibition of deoxy S polymerization by N-terminal band 3 peptides.
- To evaluate the efficacy of a mirror-image peptide in preventing deoxy S polymerization and gelation.
Main Methods:
- Time-viscosity profiles of deoxy S sol-gel transformation were analyzed.
- Gel solidity was assessed using yield temperature measurements.
- Equilibrium solubility assays were used to determine inhibition efficacy.
Main Results:
- Both N:1-15AA and mirror-image peptides increased lag times, indicating delayed polymerization.
- The mirror-image peptide was more effective, with peptide:hemoglobin ratios of 0.25-1:1 reducing effective deoxy S concentration by 15-25%.
- Mirror-image peptide reduced gel solidity compared to controls.
Conclusions:
- N-terminal band 3 peptides, particularly the mirror-image variant, effectively inhibit deoxy S polymerization.
- The proposed mechanisms involving steric hindrance and binary complex formation are supported.
- These findings suggest a promising therapeutic strategy for sickle cell disease.